Public research preview

Richard W. Allen, Representative disclosure: Abbott Laboratories Common Stock (ABT)

Disclosed a buy transaction in Abbott Laboratories Common Stock (ABT). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
24/100
Signal Quality
63/100
Data quality
93%
High quality

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
10 Aug 2023, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
1413 days

Timeline

Transaction date

27 Sept 2019

Public disclosure

10 Aug 2023

Now

Tracked today

Filing delay: 1413 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
10 Jun 2026

The pre-disclosure spike has collapsed -23.6% from its peak. Retraces deeper than 20% behaved like falling knives in the backtests, not discounts, and are excluded from the discount-entry sleeve.

Stock path

ABT from pre-transaction context through latest close.

Bought

27 Sept 2019 · 72.494 USD · Not public yet

System decision

Would not buyThe strategy's filters reject this signal. Failed filters: Filed within 30 days · Pre-disclosure move <= 35%.

Not public yetWould not buy56.196.4136.8USDDate27 Sept10 Aug8 JunOfficial disclosure10 AugBoughtDisclosureLatest
  • Not public yet
  • Would not buy
Observed transaction close
72.494
Observed disclosure close
99.099
Observed latest close
90.5
Pre-disclosure move
+36.7%
Post-disclosure move
-8.7%
Market-adjusted move
-8.7%
1w since disclosure
+0.2%
1m since disclosure
-2.2%
3m since disclosure
-9.0%
Pre-disclosure peak run-up
+79.0%
Retrace from peak
-23.6%

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $15,001 - $50,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 10 Aug 2023, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value15001
sourcehouse_stock_act
tickerABT
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20023082.pdf
personNameRichard W. Allen
amountRange$15,001 - $50,000
companyNameAbbott Laboratories (ABT)
publishedAt2023-08-10T00:00:00.000Z
rawDocumentIdraw-us-house-20023082-5
disclosureDate2023-08-10
transactionDate2019-09-27
transactionTypeP